The effects of gold nanoparticles functionalized with beta-amyloid specific peptides on an in vitro model of blood–brain barrier
Author
dc.contributor.author
Ruffa, J.
Author
dc.contributor.author
Hüwelb, S.
Author
dc.contributor.author
Kogan Bocian, Marcelo
Author
dc.contributor.author
Simon, Ulrich
Author
dc.contributor.author
Joachim Gallab, Hans
Admission date
dc.date.accessioned
2018-05-16T21:35:18Z
Available date
dc.date.available
2018-05-16T21:35:18Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Nanomedicine: NBM 13 (2017) 1645–1652
es_ES
Identifier
dc.identifier.other
http://dx.doi.org/10.1016/j.nano.2017.02.013
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/147839
Abstract
dc.description.abstract
We studied the effect of gold nanoparticle (AuNP) size, surface charge, concentration and morphology on the integrity of the blood–brain
barrier (BBB) in a well-established in vitro model set-up. We focused on the effect of peptide functionalized hollow gold nanospheres and
gold nanorods, which selectively bind to amyloidogenic β-amyloid structures. These AuNP conjugates have already been successfully tested
as photothermal absorbers for potential application in Alzheimer's disease (AD) therapy in an in vitro set-up, but may exhibit a low passage
through the BBB due to their overall negative charge. Our results show that: (i) small (1.4 nm) AuNPs strongly affects the BBB integrity, (ii)
negative surface charge impedes BBB passage, and (iii) this charge effect caused by the peptide is compensated by covalent coupling to a
polyethylene glycol ligand stabilizing the particles in diluted manner.